Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. is an American biotechnology company based in Ardsley, New York. The company develops therapies that improve neurological function in people with Parkinsons disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States.
Number of employees: 344
Index: –; Marketcap: 33.37M; Income: ; Beta: 1.57
Dividend: –; Sales past 5 years: -13.70%; Sales qq: -36.30%
Types of investors:
Insiderown: 1.49%; Insidertrans: 0.00%; Institutionalown: ; Institutionaltrans: 0.00%
Grossmargin: 83.10%; Opermargin: –; Profitmargin: –
Ebitda (2015-2019): 59.9M 11.8M 145.66M 98.48M (82.03M)